UCL School of Pharmacy, 29-39 Brunswick Square, London WC1N 1AX, United Kingdom.
Research Centre for Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria.
Eur J Pharm Biopharm. 2018 Apr;125:131-140. doi: 10.1016/j.ejpb.2018.01.003. Epub 2018 Jan 31.
The features rendering orodispersible films (ODFs) patient-centric formulations are widely discussed in the scientific literature. However there is a lack of research studies exploring ODF characteristics with a potential impact on end-user acceptability. The aim of this study was to identify the key ODF characteristics affecting end-user acceptability by developing in vitro test methods for the prediction of ODFs acceptability and correlate these formulation characteristics with the data obtained from a human panel study. Four drug-free single-polymer films were prepared by solvent casting. Solutions of poly(vinyl) alcohol (PVOH) 39 KDa (P1), PVOH 197 KDa (P2), carboxymethylcellulose (CMC) 395 KDa (C1), and CMC 725 KDa (C2) were prepared. Texture analysis and Dynamic Mechanical Analysis (DMA) were used to assess film tack. Petri dish and drop methods were used to assess disintegration time. A human panel of 24 healthy young adults was employed to identify end-user acceptability criteria of the four study film samples. Texture analysis data of ODF tack were not found to be in agreement with the in vivo perceived stickiness in the mouth. However, measurement of the area under the adhesive force curve obtained by DMA correlated with in vivo perceived stickiness data for all samples. The disintegration times obtained by drop method were more comparable to human panel data than the petri dish method. Hence DMA and drop methods proved to be promising methodologies for the prediction of the end-user acceptability. The type and molecular weight of the film-forming polymer had a strong influence on stickiness perception, whereas only polymeric molecular weight influenced perceived disintegration time. The human panel study showed that Participant Reported Outcomes (PROs) for the perceived stickiness in the mouth and disintegration time of test films received significantly different scores between samples, and thus were identified as the key attributes with the potential to affect the end-user acceptability. ODF stickiness and disintegration time should therefore be evaluated at an early stage of the drug product design.
具有口腔速崩性能(ODF)的制剂以患者为中心的特点在科学文献中被广泛讨论。然而,缺乏研究探索可能对最终用户可接受性产生影响的 ODF 特性。本研究旨在通过开发用于预测 ODF 可接受性的体外测试方法来确定影响最终用户可接受性的关键 ODF 特性,并将这些制剂特性与来自人体小组研究的数据相关联。通过溶剂浇铸制备了四种无药物的单聚合物薄膜。制备了聚(乙烯醇)39 kDa(P1)、聚(乙烯醇)197 kDa(P2)、羧甲基纤维素 395 kDa(C1)和羧甲基纤维素 725 kDa(C2)的溶液。使用质地分析和动态机械分析(DMA)评估薄膜的粘性。使用培养皿法和滴液法评估崩解时间。采用 24 名健康年轻成年人的人体小组来确定四种研究薄膜样品的最终用户可接受性标准。ODF 粘性的质地分析数据与体内口腔感知粘性不一致。然而,DMA 获得的粘着力曲线下面积的测量与所有样品的体内感知粘性数据相关。滴液法获得的崩解时间与人体小组数据更可比,而比培养皿法更可比。因此,DMA 和滴液法被证明是预测最终用户可接受性的有前途的方法。成膜聚合物的类型和分子量对粘性感知有强烈影响,而只有聚合物分子量影响感知崩解时间。人体小组研究表明,参与者报告的口腔粘性和测试薄膜崩解时间的结果在样品之间的感知差异很大,因此被确定为可能影响最终用户可接受性的关键属性。因此,在药物产品设计的早期阶段应评估 ODF 的粘性和崩解时间。